Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Big Pharma's Large Molecule Challenge

01 Sep 2004

Related Content

In Cancer, the Antibody Beat Goes On

01 Nov 2003

Protein C: Saving Lives, Saving Lilly

01 May 2001

Novartis Bucks the Trend

01 Feb 2004

A Recipe for Acquisition: the Esperion Strategy

01 Jan 2004

R&D Productivity at GSK? He CEDD, She CEDD

01 Jan 2004

Canary in the Coalmine: Pfizer R&D

01 Sep 2004

Related Companies

Eli Lilly and Company

Pfizer Inc.

AstraZeneca PLC

GSK plc

Novartis AG

Ambrx Biopharma, Inc.

GSK plc

Johnson & Johnson

Eli Lilly and Company

Egea Biosciences Inc.

NOBEX Corporation

Amgen, Inc.

Wyeth

MorphoSys AG

Amgen, Inc.

Dyax Corp

Johnson & Johnson

Medarex

Abbott

AstraZeneca PLC

Seagen Inc.

Esperion Therapeutics, Inc.

Merck KGaA

Nektar Therapeutics

Sanofi

Roche Holding AG

Additional Topics

Strategy Business Strategies Leadership BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.